Cystic fibrosis bone disease: is the CFTR corrector C18 an option for therapy?

Velard Frédéric, Delion Martial, Lemaire Flora, Tabary Olivier, Guillaume Christine, Le Pimpec Barthès Françoise, Touqui Lhousseine, Gangloff Sophie, Sermet-Gaudelus Isabelle, Jacquot Jacky

Source: Eur Respir J 2015; 45: 845-848
Journal Issue: March

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Velard Frédéric, Delion Martial, Lemaire Flora, Tabary Olivier, Guillaume Christine, Le Pimpec Barthès Françoise, Touqui Lhousseine, Gangloff Sophie, Sermet-Gaudelus Isabelle, Jacquot Jacky. Cystic fibrosis bone disease: is the CFTR corrector C18 an option for therapy?. Eur Respir J 2015; 45: 845-848

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cystic fibrosis: prospects for therapy of some class 1 mutations
Source: Annual Congress 2007 - Cystic fibrosis: will the new biology deliver?
Year: 2007


Targeting CFTR as a therapy for cystic fibrosis
Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung
Year: 2010

Cystic fibrosis and bone disease: are we missing a genetic link?
Source: Eur Respir J 2005; 25: 9-11
Year: 2005


A new gold standard for assessing CT in early CF lung disease?
Source: International Congress 2014 – Cystic fibrosis: assessment and treatment
Year: 2014

How useful is the lung ultrasound in cystic fibrosis?
Source: International Congress 2016 – Cystic fibrosis: various aspects
Year: 2016


MRI detects changes in structure and perfusion, and response to therapy in early cystic fibrosis lung disease
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014

Cystic fibrosis
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=234
Year: 2006

Cystic fibrosis related pulmonary disease: more structure than function?
Source: Eur Respir J 2005; 26: Suppl. 49, 729s
Year: 2005

Lung inflammation in cystic fibrosis: an overlooked therapeutic target?
Source: Virtual Congress 2020 – Cystic fibrosis: from cradle to old age
Year: 2020


Update on new treatments for cystic fibrosis
Source: Virtual Congress 2020 – Updates in cystic fibrosis
Year: 2020


Gene therapy for cystic fibrosis: successes and challenges
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=79
Year: 2006

Revisiting α1-antitrypsin therapy in cystic fibrosis: can it still offer promise?
Source: Eur Respir J 2007; 29: 229-230
Year: 2007


Trying to find a cure for cystic fibrosis: CFTR biomarkers as outcomes
Source: Eur Respir J 2013; 42: 1156-1157
Year: 2013


Trying to find a cure for cystic fibrosis: CFTR biomarkers as outcomes
Source: Eur Respir J 2013; 42: 1155
Year: 2013


Monitoring early lung disease in cystic fibrosis: where are we now?
Source: Breathe 2014; 10: 34-47
Year: 2014



Lung function, weight, and sweat chloride responses in patients with cystic fibrosis and the G551D-CFTR mutation treated with ivacaftor: A secondary analysis
Source: Annual Congress 2013 –Cystic fibrosis: lung function and change of lung function in infants and children before and after treatment
Year: 2013


Correction of CFTR function in intestinal organoids to guide treatment of cystic fibrosis
Source: Eur Respir J, 57 (1) 1902426; 10.1183/13993003.02426-2019
Year: 2021



Combination therapy in idiopathic pulmonary fibrosis: the way ahead will be hard
Source: Eur Respir J 2015; 45: 1208-1210
Year: 2015


Does this patient have cystic fibrosis? 
Source: International Congress 2017 – GR6 Paediatric Ground Round: an interactive session
Year: 2017


Lung retransplantation in cystic fibrosis (CF). Is it justifiable?
Source: Annual Congress 2008 - Donor organs and complications after lung transplantation
Year: 2008